Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation

Anuraag R. Kansal; Ying Zheng; Tiffany Pokora; Sonja V. Sorensen

doi:10.1016/j.beha.2013.07.012

Cost-effectiveness of new oral anticoagulants in the prevention of stroke in patients with atrial fibrillation

Best Practice & Research Clinical Haematology ◽

10.1016/j.beha.2013.07.012 ◽

2013 ◽

Vol 26 (2) ◽

pp. 225-237 ◽

Cited By ~ 23

Author(s):

Anuraag R. Kansal ◽

Ying Zheng ◽

Tiffany Pokora ◽

Sonja V. Sorensen

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Oral Anticoagulants ◽

New Oral Anticoagulants

Download Full-text

COST EFFECTIVENESS OF ORAL ANTICOAGULATION THERAPY FOR NON-VALVULAR ATRIAL FIBRILLATION PATIENTS: WARFARIN VERSUS THE NEW ORAL ANTICOAGULANTS RIVAROXABAN, DABIGATRAN AND APIXABAN

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(18)31031-3 ◽

2018 ◽

Vol 71 (11) ◽

pp. A490 ◽

Cited By ~ 2

Author(s):

Ismael Ortiz-Cartagena ◽

Antonio Orraca Gotay ◽

Jose Acevedo

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Oral Anticoagulation ◽

Oral Anticoagulants ◽

Anticoagulation Therapy ◽

New Oral Anticoagulants ◽

Oral Anticoagulation Therapy

Download Full-text

Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation

Value in Health ◽

10.1016/j.jval.2013.01.009 ◽

2013 ◽

Vol 16 (4) ◽

pp. 498-506 ◽

Cited By ~ 87

Author(s):

Doug Coyle ◽

Kathryn Coyle ◽

Chris Cameron ◽

Karen Lee ◽

Shannon Kelly ◽

...

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Cardiovascular Events ◽

Oral Anticoagulants ◽

New Oral Anticoagulants

Download Full-text

Cost-Effectiveness Analysis of New Oral Anticoagulants Compared To Warfarin In Thai Patients With Non-Valvular Atrial Fibrillation

Value in Health ◽

10.1016/j.jval.2018.07.234 ◽

2018 ◽

Vol 21 ◽

pp. S30-S31

Author(s):

P Dilokthornsakul ◽

S Nathisuwan ◽

R Krittayaphong ◽

A Chutinet ◽

U Permsuwan

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Oral Anticoagulants ◽

Cost Effectiveness Analysis ◽

New Oral Anticoagulants ◽

Effectiveness Analysis

Download Full-text

Cost-effectiveness of new oral anticoagulants and warfarin in atrial fibrillation from adverse events perspective

Revista Colombiana de Cardiología ◽

10.1016/j.rccar.2018.10.011 ◽

2019 ◽

Vol 26 (2) ◽

pp. 70-77

Author(s):

José A. Mendoza ◽

Federico A. Silva ◽

Lady M. Rangel

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Adverse Events ◽

Oral Anticoagulants ◽

New Oral Anticoagulants

Download Full-text

New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness

Drug Design Development and Therapy ◽

10.2147/dddt.s45644 ◽

2014 ◽

pp. 789 ◽

Cited By ~ 66

Author(s):

Helen Mani ◽

Edelgard Lindhoff-Last

Keyword(s):

Quality Of Life ◽

Atrial Fibrillation ◽

Cost Effectiveness ◽

Oral Anticoagulants ◽

New Oral Anticoagulants ◽

Nonvalvular Atrial Fibrillation

Download Full-text

Cost-effectiveness of non-vitamin K antagonist oral anticoagulants for atrial fibrillation in PortugalCost-effectiveness of new oral anticoagulants in Portuguese atrial fibrillation patients

Revista Portuguesa de Cardiologia (English Edition) ◽

10.1016/j.repce.2015.11.005 ◽

2015 ◽

Vol 34 (12) ◽

pp. 723-737

Author(s):

João Costa ◽

Francesca Fiorentino ◽

Daniel Caldeira ◽

Mónica Inês ◽

Catarina Lopes Pereira ◽

...

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Vitamin K ◽

Oral Anticoagulants ◽

Vitamin K Antagonist ◽

New Oral Anticoagulants

Download Full-text

Cost-effectiveness of new oral anticoagulants for patients with atrial fibrillation – a decision analysis

Value in Health ◽

10.1016/j.jval.2013.03.1482 ◽

2013 ◽

Vol 16 (3) ◽

pp. A285-A286

Author(s):

J. You

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Decision Analysis ◽

Oral Anticoagulants ◽

New Oral Anticoagulants

Download Full-text

Cost-Effectiveness of Apixaban Versus Other New Oral Anticoagulants And Warfarin for Stroke Prevention In Atrial Fibrillation In Venezuela

Value in Health ◽

10.1016/j.jval.2015.09.309 ◽

2015 ◽

Vol 18 (7) ◽

pp. A829 ◽

Cited By ~ 2

Author(s):

Y Fernández Ávila ◽

KC Garcia ◽

S Garrido Lecca ◽

BM Donato ◽

A Juarez-Garcia

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Stroke Prevention ◽

Oral Anticoagulants ◽

New Oral Anticoagulants

Download Full-text

Cost Effectiveness of New Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation in Two Different European Healthcare Settings

American Journal of Cardiovascular Drugs ◽

10.1007/s40256-014-0092-1 ◽

2014 ◽

Vol 14 (6) ◽

pp. 451-462 ◽

Cited By ~ 28

Author(s):

Talitha I. Verhoef ◽

William K. Redekop ◽

Fazila Hasrat ◽

Anthonius de Boer ◽

Anke Hilse Maitland-van der Zee

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Stroke Prevention ◽

Oral Anticoagulants ◽

New Oral Anticoagulants ◽

Healthcare Settings ◽

European Healthcare

Download Full-text

C0153 Evaluation of atrial fibrillation population in apulia region for the cost/effectiveness analysis for the use of old and new oral anticoagulants: Cooperation of hematologist, cardiologist and internist

Thrombosis Research ◽

10.1016/j.thromres.2012.08.237 ◽

2012 ◽

Vol 130 ◽

pp. S191-S192

Author(s):

Nicola Ciavarella ◽

Paolo Colonna ◽

Ennio Michelotto ◽

Vito Lepore ◽

Fabio Robusto ◽

...

Keyword(s):

Atrial Fibrillation ◽

Cost Effectiveness ◽

Oral Anticoagulants ◽

Cost Effectiveness Analysis ◽

New Oral Anticoagulants ◽

Apulia Region ◽

Effectiveness Analysis ◽

The Cost

Download Full-text